HCPLive Network
Latest Family Practice Headlines
Wednesday, November 26, 2014
By Adam Hochron
No matter what reason a patient is in the intensive care unit (ICU) of a hospital every moment and medication they take matters in helping them recover. A recent study looked at what dose of systemic corticosteroids should be given to patients with chronic obstructive pulmonary disease (COPD) exacerbations during their time in critical care.
Wednesday, November 26, 2014
By Rachel Lutz
Hepatitis C virus, fibrosis, and cirrhosis patients with sustained virological response can have survival rates comparable to the general population, according to research published in JAMA.
Wednesday, November 26, 2014
The number of emergency department visits in the United States rose from 129.8 million in 2010 to a record 136.3 million in 2011, according to the US Centers for Disease Control and Prevention.
Wednesday, November 26, 2014
For low-income adults with uncontrolled asthma, home visitation by community health workers is associated with improvements in asthma control and quality of life, according to a study published online Nov. 24 in JAMA Internal Medicine.
Tuesday, November 25, 2014
By Rachel Lutz
Glucose intolerances may be linked to non-caloric artificial sweeteners, according to research published in Nature.
Tuesday, November 25, 2014
By Rachel Lutz
Research teams examining the safety and efficacy of zanamivir and oseltamivir for influenza treatment concluded they are not as effective as popularly believed.
Tuesday, November 25, 2014
By Rachel Lutz
HDL cholesterol may have atheroprotective qualities, according to a report from The New England Journal of Medicine.
Tuesday, November 25, 2014
By Amy Jacob
Study results published in the European Respiratory Journal show that rates of inflammatory bowel disease (IBD) incidence have significantly increased in individuals with asthma or chronic obstructive pulmonary disease (COPD).
Tuesday, November 25, 2014
By Amy Jacob
Regeneron Pharmaceuticals, Inc. and Sanofi recently announced the US food and Drug Administration (FDA) granted Breakthrough Therapy designation to dupilumab, a fully-human monoclonal antibody, to treat adults suffering from moderate to severe atopic dermatitis (AD)who had an insufficient response to or who were not suitable for topical prescription therapy.
Tuesday, November 25, 2014
Most older Americans qualify for treatment with statins under new guidelines for the treatment of blood cholesterol released late last year by the American College of Cardiology and the American Heart Association. The findings appear in a research letter published online Nov. 17 in JAMA Internal Medicine.
Physician's Money Digest
With the advent of ongoing audits for medical necessity and accurate coding, whose documentation is being scrutinized to ensure that the medical services being provided are reasonable and necessary? The answer: physicians.
With the holiday shopping season now upon us, the potential for damaging one’s credit –- either via over-spending or being the victim of identity theft –- is high.